Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 2/20 | 0.40 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | PPARD | Q03181 | 1/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
| ▸ | NTRK1 | P04629 | 3/20 | 0.36 |
| ▸ | NTRK3 | Q16288 | 3/20 | 0.36 |
| ▸ | NTRK2 | Q16620 | 3/20 | 0.36 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.36 |
| ▸ | GRM5 | P41594 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13572449 | 0.92 | MAPT (0.36) | LTA4HMCHR1PPARGPPARDPPARA | |
| SCHEMBL6792781 | 0.88 | ALDH1A1 (0.34) | MCHR1PPARGPPARDPPARAMAPT | |
| SCHEMBL13572446 | 0.85 | MCHR1 (0.35) | LTA4HMCHR1PPARGPPARDPPARA | |
| SCHEMBL13572451 | 0.82 | GRM5 (0.38) | PPARGPPARDPPARAPTPN11GRM5 | |
| SCHEMBL14706340 | 0.82 | MCHR1 (0.32) | MCHR1PPARGPPARDPPARAMAPT | |
| SCHEMBL6793004 | 0.80 | ALDH1A1 (0.32) | MCHR1PPARGPPARDPPARAMAPT | |
| SCHEMBL14706336 | 0.79 | PPARG (0.36) | PPARGPPARDPPARAPTPN11TP53 | |
| SCHEMBL24011802 | 0.77 | NR1H2 (0.47) | PPARGPPARA | |
| SCHEMBL12869345 | 0.77 | THRB (0.34) | PPARGPPARDPPARAGRM5TP53 | |
| SCHEMBL18873949 | 0.77 | GRM5 (0.44) | NTRK1NTRK3NTRK2GRM5MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6806368-B2 | FOR ELECTRONIC, OPTOELECTRONIC AND PHOTONIC APPLICATIONS, FOR COLORATION OF MACROMOLECULAR ORGANIC AND OF INORGANIC MATERIALS | BASF AKTIENGESELLSCHAFT (DE) | 2004-10-19 | — | — | US | disclosed |
| US-20030181721-A1 | Liquid crystalline 3,4:9,10-perylenetetacarbocylic acid diimides | BASF AKTIENGESELLSCHAFT (DE) | 2003-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030181721-A1 | Liquid crystalline 3,4:9,10-perylenetetacarbocylic acid diimides | CCR9, CLTA, HAO2 | LTA4H 556/4885MCHR1 858/4885PPARG 2022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.